577 filings
Page 3 of 29
8-K
yn4t6vj2j45r7zkqm yk
24 Sep 21
Submission of Matters to a Vote of Security Holders
5:26pm
8-K
hko9eiic
10 Aug 21
Altimmune Announces Second Quarter 2021 Financial Results
4:07pm
8-K
2stw9htwj9k
29 Jun 21
Altimmune Announces Update on AdCOVIDTM Phase 1 Clinical Trial
4:30pm
8-K
k4us8b1oc4u56xha9
16 Jun 21
Altimmune Announces Positive Interim Data from ALT-801 Phase 1 Trial in Overweight and Obese Volunteers
7:15am
8-K
u0qx6
17 May 21
Altimmune Announces First Quarter 2021 Financial Results
7:05am
8-K
4ktjjhdkggt nol1cpbe
1 Apr 21
Other Events
7:30am
8-K
hymgtr10bpo et9
12 Mar 21
Entry into a Material Definitive Agreement
6:08am
8-K
ln3c1bma gx4l
25 Feb 21
Entry into a Material Definitive Agreement
4:06pm
424B5
dtb36pn0o073rxucw ix
25 Feb 21
Prospectus supplement for primary offering
8:19am
8-K
4grd7j0q8xlv116exbll
25 Feb 21
Enrollment in the Phase 1 AdCOVID™ Clinical Trial has Commenced
7:06am
EFFECT
79j5z2t22em1jbcy21k
12 Jan 21
Notice of effectiveness
12:15am
UPLOAD
6r0xyb2svq58mu9jc8
7 Jan 21
Letter from SEC
12:00am
CORRESP
lnriqp0h0jpd0n1
7 Jan 21
Correspondence with SEC
12:00am
8-K
ygmo0qttp
23 Dec 20
Altimmune Provides an Update on its Investigational New Drug Application
4:20pm